<DOC>
	<DOCNO>NCT02533947</DOCNO>
	<brief_summary>Studies suggest patient hematological malignancy undergo allogeneic hematopoietic stem cell transplantation ( HSCT ) risk cognitive decline long-term cognitive dysfunction . To address issue , randomize control intervention trial effect physical exercise cognition conduct . In addition , impact psychological physical health outcome evaluate . Results may benefit patient suffer disease- treatment-associated cognitive change .</brief_summary>
	<brief_title>Cognition Allogeneic Stem Cell Transplanted Patients Sports</brief_title>
	<detailed_description>Studies suggest patient hematological malignancy undergo allogeneic hematopoietic stem cell transplantation ( HSCT ) risk cognitive decline long-term cognitive dysfunction . To address issue , randomize control intervention trial effect physical exercise cognition conduct . In addition , impact psychological physical health outcome depression , fatigue , health-related quality life physical fitness evaluate . A healthy control group match patient age , gender , education include control practice effect neuropsychological measure allow additional comparison self-report measure . The healthy control group undergo neuropsychological test questionnaire survey baseline 4 month . Demographic data collect study participant baseline . Medical data collect patient time point . Results may benefit patient suffer disease- treatment-associated cognitive change .</detailed_description>
	<criteria>Patients : hematological malignancy ( AML , ALL , MDS , OMF , CML , MM , NHL , Hodgkin , AA ) 3 6 month allogeneic HSCT ≥ 18 year age time transplantation German mother tongue regular followup visit transplantation center first year transplantation &gt; 75 year age time transplantation relapse/progress thrombocyte count ≤ 50 G/l GvHD lung involvement compromise lung function ( patient need oxygen ) compromise cardiovascular function ( &lt; 10m walk ) florid infection immobility neurological disease severe psychiatric disease regular intake psychoactive drug substance abuse uncontrolled diabetes high fracture risk impair vision and/or hear Healthy control ( match age , gender , education ) : ≥ 18 year age time enrolment German mother tongue residence area transplantation center family members/friends accompany patient clinical followup visit &gt; 75 year age time enrolment hematological malignancy solid tumour disease bone joint disorder neurological disease severe psychiatric disease regular intake psychoactive drug substance abuse uncontrolled diabetes impaired vision and/or hear</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Allogeneic Stem Cell Transplantation</keyword>
	<keyword>Hematological Malignancies</keyword>
	<keyword>Exercise Intervention</keyword>
	<keyword>Cognitive Function</keyword>
	<keyword>Fatigue</keyword>
	<keyword>Randomized Controlled Trial</keyword>
</DOC>